Compare · LEVI vs PASW
LEVI vs PASW
Side-by-side comparison of Levi Strauss & Co (LEVI) and Ping An Biomedical Co. Ltd. (PASW): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LEVI and PASW operate in Apparel (Consumer Discretionary), so they compete in similar markets.
- LEVI is the larger of the two at $9.44B, about 625.1x PASW ($15.1M).
- Over the past year, LEVI is up 27.5% and PASW is down 91.8% - LEVI leads by 119.3 points.
- LEVI has been more active in the news (6 items in the past 4 weeks vs 2 for PASW).
- LEVI has more recent analyst coverage (25 ratings vs 0 for PASW).
- Company
- Levi Strauss & Co
- Ping An Biomedical Co. Ltd.
- Price
- $24.52-0.10%
- $0.13+13.74%
- Market cap
- $9.44B
- $15.1M
- 1M return
- +0.06%
- -17.14%
- 1Y return
- +27.47%
- -91.82%
- Industry
- Apparel
- Apparel
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 1999
- News (4w)
- 6
- 2
- Recent ratings
- 25
- 0
Levi Strauss & Co
Levi Strauss & Co. operates as an apparel company. It designs, markets, and sells jeans, casual and dress pants, tops, shorts, skirts, jackets, footwear, and related accessories for men, women, and children in the Americas, Europe, and Asia. The company sells its products under the Levi's, Dockers, Signature by Levi Strauss & Co., and Denizen brands; and also licenses its Levi's and Dockers trademarks for various product categories, including footwear, belts, wallets and bags, outerwear, sweaters, dress shirts, kids wear, sleepwear, and hosiery. The company sells its products through third-party retailers, such as department stores, specialty retailers, third-party e-commerce sites, and franchisees who operate brand-dedicated stores; and directly to consumers through various formats, including company-operated mainline and outlet stores, company-operated e-commerce sites, and select shop-in-shops located in department stores and other third-party retail locations. It operates approximately 3,100 brand-dedicated stores and shop-in-shops. The company was founded in 1853 and is headquartered in San Francisco, California.
Latest LEVI
- EVP & Chief Commercial Officer Flore Gianluca covered exercise/tax liability with 27,429 shares, decreasing direct ownership by 15% to 157,187 units (SEC Form 4) (withholding tax)
- Levi Strauss downgraded by Wells Fargo with a new price target
- EVP & Chief Fin. & Growth Ofc. Singh Harmit J converted options into 17,425 shares, exercised 335,476 shares at a strike of $19.46, covered exercise/tax liability with 304,757 shares and sold $2,377,048 worth of shares (98,144 units at $24.22) as part of a pre-agreed trading plan, decreasing direct ownership by 34% to 98,747 units (SEC Form 4)
- SEC Form 10-Q filed by Levi Strauss & Co
- Levi Strauss & Co filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Levi Strauss & Co. Reports Second-Quarter Results
- Levi Strauss & Co. to Webcast Second Quarter 2026 Earnings Conference Call
- Levi Strauss & Co filed SEC Form 8-K: Leadership Update
- Large owner Haas Robert D. converted options into 202,135 shares and sold $4,855,606 worth of shares (202,135 units at $24.02) (SEC Form 4)
- Large owner Peter E. Haas Jr. Family Fund converted options into 145,662 shares and sold $3,497,112 worth of shares (145,662 units at $24.01) as part of a pre-agreed trading plan (SEC Form 4)
Latest PASW
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- SEC Form 3 filed by new insider Liu Pijun (Pjl)
- SEC Form 3 filed by new insider Liu Xianzhi (Xzl)
- SEC Form 3 filed by new insider Yang Hongli (Hly)
- SEC Form 6-K filed by Ping An Biomedical Co. Ltd.
- All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital
- SEC Form 3 filed by Ping An Biomedical Co. Ltd.
- SEC Form 3 filed by Ping An Biomedical Co. Ltd.